Dublin, Feb. 20, 2025 (GLOBE NEWSWIRE) — The “Sterility Testing – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering.
The global market for Sterility Testing was valued at USD 216.4 Million in 2024 and is projected to reach USD 401.8 Million by 2030, growing at a CAGR of 10.9% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the sterility testing market is driven by several factors, including rising emphasis on product safety, quality assurance, and compliance in pharmaceutical manufacturing, technological advancements in rapid sterility testing, automated systems, and microbial detection, and the increasing adoption of sterility testing in pharmaceuticals, biologics, and medical devices. The need to provide reliable, high-sensitivity, and cost-effective sterility testing solutions for various applications is driving the demand for sterility testing across multiple sectors.
Technological innovations in closed-system testing, rapid microbiological methods, AI-driven data analytics, and digital monitoring, coupled with advancements in test methods, contamination control, and quality management systems, are enhancing the efficiency, accuracy, and marketability of sterility testing, supporting market growth. The expansion of sterility testing applications in cell therapy, gene therapy, personalized medicine, and biosimilars, along with the growing emphasis on contamination risk assessment, environmental monitoring, and regulatory compliance, is creating new opportunities for market players.
Additionally, the focus on developing robust, rapid, and GMP-compliant sterility testing solutions for diverse biopharmaceutical and medical device needs is further propelling the growth of the sterility testing market.
Report Scope
The report analyzes the Sterility Testing market, presented in terms of market value (USD Thousand). The analysis covers the key segments and geographic regions outlined below.
Segments
Product (Kits & Reagents, Instruments, Services); Test (Membrane Filtration, Direct Inoculation, Other Tests); Application (Pharmaceutical & Biotechnology Manufacturing, Medical Devices Manufacturing, Other Applications).
Geographic Regions/Countries
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Sterility Testing Kits & Reagents segment, which is expected to reach $184.9 Million by 2030 with a CAGR of a 12.2%. The Sterility Testing Instruments segment is also set to grow at 9.5% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $57 Million in 2024, and China, forecasted to grow at an impressive 14.8% CAGR to reach $92.1 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in USD from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as bioMerieux SA, Charles River Laboratories International, Inc., Danaher Corporation, INDICIA, Nelson Laboratories, LLC and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Questions Answered:
- How is the Global Sterility Testing Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Some of the 44 major companies featured in this Sterility Testing market report include:
- bioMerieux SA
- Charles River Laboratories International, Inc.
- Danaher Corporation
- INDICIA
- Nelson Laboratories, LLC
- Pacific Biolabs
- Sartorius AG
- SGS SA
- Thermo Fisher Scientific, Inc.
- Toxikon Corporation
Key Attributes
Report Attribute | Details |
No. of Pages | 174 |
Forecast Period | 2024-2030 |
Estimated Market Value (USD) in 2024 | $216.4 Million |
Forecasted Market Value (USD) by 2030 | $401.8 Million |
Compound Annual Growth Rate | 10.9% |
Regions Covered | Global |
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Sterility Testing – Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
MARKET TRENDS & DRIVERS
- Rising Emphasis on Product Safety, Quality Assurance, and Compliance Drives Demand for Sterility Testing
- Technological Advancements in Rapid Sterility Testing, Automated Systems, and Microbial Detection Propel Innovation
- Increasing Use of Sterility Testing in Pharmaceuticals, Biologics, and Medical Devices Expands Addressable Market Opportunity
- Focus on Accelerated Testing Methods, Real-Time Monitoring, and Data Integrity Strengthens Business Case for Sterility Testing
- Emergence of Closed System Sterility Testing, Endotoxin Detection, and Contamination Control Solutions Enhances Market Offerings
- Rising Adoption of Sterility Testing in Cell Therapy, Gene Therapy, and Personalized Medicine Fuels Market Growth
- Shift Toward Digitalization, AI, and Machine Learning in Sterility Testing Supports Market Competitiveness
- Expansion of Sterility Testing Applications in Vaccines, Blood Products, and Biosimilars Spurs Market Potential
- Increasing Emphasis on Contamination Risk Assessment, Environmental Monitoring, and Quality Management Systems Creates Market Opportunities
- Focus on Collaborations Between Pharmaceutical Companies, CROs, and Quality Control Labs Drives Market Expansion
For more information about this report visit https://www.researchandmarkets.com/r/ahohrl
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.